9 3 39 (Lamotrigine 25 mg)

Pill imprint 9 3 39 has been identified as Lamotrigine 25 mg.

Lamotrigine is used in the treatment of bipolar disorder; seizure prevention; schizoaffective disorder; anxiety; restless legs syndrome (and more), and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 25 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 9 3 39

Lamotrigine 25 mg 9 3 39
Lamotrigine
Imprint:
9 3
39
Strength:
25 mg
Color:
White
Size:
8.00 mm
Shape:
Four-sided
Availability:
Prescription only
Drug Class:
Triazine anticonvulsants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00093-0039
Inactive Ingredients:
silicon dioxide
lactose monohydrate
magnesium stearate
microcrystalline cellulose
povidone k30
corn starch
sodium starch glycolate type A potato

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)